ArticleThe journal of allergy and clinical immunology. Global2025
Elevated mepolizumab levels in patients with severe asthma responsive to 1 year's mepolizumab treatment.
Takayasu Nishimaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.